Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA7 | P43166 | 4/20 | 0.33 |
| ▸ | CA9 | Q16790 | 4/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.32 |
| ▸ | SELL | P14151 | 1/20 | 0.31 |
| ▸ | SELP | P16109 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6633438 | 0.78 | CA12 (0.48) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL6633958 | 0.78 | CA1 (0.38) | ALDH1A1ALOX15CYP1A2AKR1C3CA12 | |
| SCHEMBL6631347 | 0.78 | SELL (0.45) | ALDH1A1ALOX15CYP1A2CA12CA1 | |
| SCHEMBL8641020 | 0.77 | TDP1 (0.38) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL8644706 | 0.77 | KDM4E (0.38) | ALDH1A1ALOX15CYP1A2AKR1C3KDM4E | |
| SCHEMBL7771345 | 0.77 | KMT2A (0.39) | ALDH1A1ALOX15CYP1A2AKR1C3KDM4E | |
| SCHEMBL6718464 | 0.72 | CA1 (0.41) | ALDH1A1ALOX15CA12CA1CA2 | |
| SCHEMBL6630726 | 0.72 | ALDH1A1 (0.36) | ALDH1A1ALOX15CYP1A2AKR1C3CA1 | |
| SCHEMBL6630725 | 0.72 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2HSD17B10TSHR | |
| SCHEMBL8529933 | 0.72 | ALDH1A1 (0.43) | ALDH1A1ALOX15CYP1A2AKR1C3CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117695256-A | Preparation method of functional lutein compound and application of functional lutein compound in relieving xerophthalmia | 大连工业大学 | 2024-03-15 | — | — | CN | claimed |
| CN-115005536-B | Seamless line-pressing type down jacket fabric and preparation method thereof | 高梵(浙江)信息技术有限公司 | 2023-09-26 | — | — | CN | claimed |
| CN-114940825-B | Mirror silica gel and preparation method thereof | 凤阳加松新型材料科技有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-113650390-B | Preparation method of antibacterial anti-fouling fabric | 高梵(浙江)信息技术有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-115195179-B | Seamless line-pressing type down jacket manufacturing equipment and process | 高梵(浙江)信息技术有限公司 | 2023-06-02 | — | — | CN | claimed |
| US-20200347248-A1 | PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE | ENVISTA (US) | 2020-11-05 | — | — | US | claimed |
| US-20200347247-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | ENVISTA (US) | 2020-11-05 | — | — | US | claimed |
| US-10689407-B2 | Photo-cleavable primer compositions and methods of use | ENVISTA (US) | 2020-06-23 | — | — | US | claimed |
| EP-3408253-A1 | PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE | Acatechol, Inc. (US) | 2018-12-05 | — | — | EP | claimed |
| EP-3408272-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | Acatechol, Inc. (US) | 2018-12-05 | — | — | EP | claimed |
| US-20170217999-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | ORMCO CORPORATION | 2017-08-03 | — | — | US | claimed |
| WO-2017132484-A1 | PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE | ACatechol, Inc. (US) | 2017-08-03 | — | — | WO | claimed |
| WO-2017132463-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | ACatechol, Inc. (US) | 2017-08-03 | — | — | WO | claimed |
| US-20170217997-A1 | PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE | ORMCO CORPORATION | 2017-08-03 | — | — | US | claimed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | claimed |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | claimed |
| EP-2147310-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | University of Rochester (US) | 2010-01-27 | — | — | EP | claimed |
| WO-2009020677-A9 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIV ROCHESTER (US) | 2009-04-16 | — | — | WO | claimed |
| WO-2009020677-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2009-02-12 | — | — | WO | claimed |
| US-20060049052-A1 | Ampholytic buffer having high buffering capacity and high conductivity in isoelectric form | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2006-03-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217999-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | SP1, GPER1, GRIN1 | ALDH1A1 1177/4885ALOX15 3081/4885CYP1A2 2409/4885 |
| US-20200347247-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | SP1, GPER1, GRIN1 | ALDH1A1 1177/4885ALOX15 3081/4885CYP1A2 2409/4885 |
| US-20200347248-A1 | PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE | SP1, GPER1, ESR1 | ALDH1A1 869/4885ALOX15 1816/4885CYP1A2 1386/4885 |
| US-20170217997-A1 | PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE | SP1, GPER1, ESR1 | ALDH1A1 869/4885ALOX15 1816/4885CYP1A2 1386/4885 |
| US-20060049052-A1 | Ampholytic buffer having high buffering capacity and high conductivity in isoelectric form | ALPP, CA2, CA1 | ALDH1A1 4582/4885ALOX15 4140/4885CYP1A2 4830/4885 |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | GNAI1, GNAI3, GNAI2 | ALDH1A1 4720/4885ALOX15 3602/4885CYP1A2 4839/4885 |
| US-10689407-B2 | Photo-cleavable primer compositions and methods of use | SP1, GPER1, ESR1 | ALDH1A1 869/4885ALOX15 1816/4885CYP1A2 1386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.